My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 496

    1.

    Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer.

    Papantoniou VJ, Souvatzoglou MA, Valotassiou VJ, Louvrou AN, Ambela C, Koutsikos J, Lazaris D, Christodoulidou JK, Sotiropoulou MG, Melissinou MJ, Perperoglou A, Tsiouris S, Zerva CJ.

    Breast Cancer Res. 2004;6(2):R56-62. Epub 2003 Dec 11.PMID: 14979918 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography.

    Papantoniou V, Tsiouris S, Mainta E, Valotassiou V, Souvatzoglou M, Sotiropoulou M, Nakopoulou L, Lazaris D, Louvrou A, Melissinou M, Tzannetaki A, Pirmettis I, Koutsikos J, Zerva C.

    Breast Cancer Res. 2005;7(1):R33-45. Epub 2004 Nov 8.PMID: 15642168 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Uptake and washout of 99mTcV-dimercaptosuccinic acid and 99mTc-sestamibi in the assessment of histological type and grade in breast cancer.

    Papantoniou V, Christodoulidou J, Papadaki E, Valotassiou V, Souvatzoglou M, Louvrou A, Feida H, Sotiropoulou M, Pampouras G, Michalas S, Zerva C.

    Nucl Med Commun. 2002 May;23(5):461-7.PMID: 11973487 [PubMed - indexed for MEDLINE]Related articles

    4.

    99mTc-(V)DMSA scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI.

    Papantoniou V, Christodoulidou J, Papadaki E, Valotassiou V, Stipsanelli A, Louvrou A, Lazaris D, Sotiropoulou M, Pampouras G, Keramopoulos A, Michalas S, Zerva C.

    Eur J Nucl Med. 2001 Jul;28(7):923-8.PMID: 11504092 [PubMed - indexed for MEDLINE]Related articles

    5.

    Correlation between uptake of Tc-99m sestaMIBI and prognostic factors of breast cancer.

    Cwikla JB, Buscombe JR, Kolasinska AD, Parbhoo SP, Thakrar DS, Hilson AJ.

    Anticancer Res. 1999 May-Jun;19(3B):2299-304.PMID: 10472348 [PubMed - indexed for MEDLINE]Related articles

    6.

    Scintimammographic detection of usual ductal breast hyperplasia with increased proliferation rate at risk for malignancy.

    Papantoniou V, Tsiouris S, Koutsikos J, Sotiropoulou M, Mainta E, Lazaris D, Valsamaki P, Melissinou M, Zerva C, Antsaklis A.

    Nucl Med Commun. 2006 Nov;27(11):911-7.PMID: 17021432 [PubMed - indexed for MEDLINE]Related articles

    7.

    The prognostic value of p53 and c-erbB-2 expression, proliferative activity and angiogenesis in node-negative breast carcinoma.

    Erdem O, Dursun A, Coşkun U, Günel N.

    Tumori. 2005 Jan-Feb;91(1):46-52.PMID: 15850004 [PubMed - indexed for MEDLINE]Related articles

    8.

    Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.

    Basu S, Chen W, Tchou J, Mavi A, Cermik T, Czerniecki B, Schnall M, Alavi A.

    Cancer. 2008 Mar 1;112(5):995-1000.PMID: 18098228 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Correlation between 99mTc-MIBI uptake and angiogenesis in MIBI-positive breast lesions.

    Bekiş R, Degirmenci B, Aydin A, Ozdogan O, Canda T, Durak H.

    Nucl Med Biol. 2005 Jul;32(5):465-72.PMID: 15982577 [PubMed - indexed for MEDLINE]Related articles

    10.

    Scintimammographic findings of phyllodes tumor of the breast in a double-phase study with Tc-99m (V)DMSA and Tc-99m MIBI: a case report.

    Papantoniou V, Koutsikos J, Sotiropoulou M, Mainta E, Lazaris D, Tsiouris S, Zerva C.

    Jpn J Clin Oncol. 2004 Jul;34(7):429-31.PMID: 15342672 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases.

    Wang-Rodriguez J, Cross K, Gallagher S, Djahanban M, Armstrong JM, Wiedner N, Shapiro DH.

    Mod Pathol. 2002 Aug;15(8):853-61.PMID: 12181271 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.

    Suthipintawong C, Wejaranayang C, Vipupinyo C.

    J Med Assoc Thai. 2008 Dec;91(12):1779-84.PMID: 19133508 [PubMed - indexed for MEDLINE]Related articles

    13.

    Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.

    Rudolph P, Olsson H, Bonatz G, Ratjen V, Bolte H, Baldetorp B, Fernö M, Parwaresch R, Alm P.

    J Pathol. 1999 Jan;187(2):207-16.PMID: 10365096 [PubMed - indexed for MEDLINE]Related articles

    14.

    Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.

    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.

    BMC Cancer. 2007 Apr 12;7:63.PMID: 17430582 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.

    Papantoniou V, Sotiropoulou E, Valsamaki P, Tsaroucha A, Sotiropoulou M, Ptohis N, Stipsanelli A, Dimitrakakis K, Marinopoulos S, Tsiouris S, Antsaklis A.

    Breast Cancer. 2010 Feb 9. [Epub ahead of print]PMID: 20143189 [PubMed - as supplied by publisher]Related articles

    16.

    Expression of drug resistance protein related to Tc-99m MIBI breast imaging.

    Sun SS, Hsieh JF, Tsai SC, Ho YJ, Kao CH.

    Anticancer Res. 2000 May-Jun;20(3B):2021-5.PMID: 10928145 [PubMed - indexed for MEDLINE]Related articles

    17.

    Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions.

    Ambrus E, Rajtár M, Ormándi K, Séra T, Tószegi A, Láng J, Pávics L, Csernay L.

    Anticancer Res. 1997 May-Jun;17(3B):1599-605.PMID: 9179201 [PubMed - indexed for MEDLINE]Related articles

    18.

    Dynamic imaging: scintimammography.

    Salvatore M, Del Vecchio S.

    Eur J Radiol. 1998 May;27 Suppl 2:S259-64. Review.PMID: 9652532 [PubMed - indexed for MEDLINE]Related articles

    19.

    Incremental diagnostic value of quantitative analysis of double phase Tc-99m MIBI scintimammography for the detection of primary breast cancer additive to visual analysis.

    Kim SJ, Kim IJ, Bae YT, Kim YK, Kim DS.

    Breast Cancer Res Treat. 2004 Jan;83(2):129-38.PMID: 14997043 [PubMed - indexed for MEDLINE]Related articles

    20.

    Role of thallium-201 chloride and Tc-99m methoxy-isobutyl-isonitrite (sestaMIBI) in evaluation of breast masses: correlation with the immunohistochemical characteristic parameters (Ki-67, PCNA, Bcl, and angiogenesis) in malignant lesions.

    Omar WS, Eissa S, Moustafa H, Farag H, Ezzat I, Abdel-Dayem HM.

    Anticancer Res. 1997 May-Jun;17(3B):1639-44.PMID: 9179210 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk